By Pete Brush ( December 22, 2009, 4:24 PM EST) -- Bessie Flemings, a Mississippi woman whose bellwether case over Merck & Co. Inc. osteoporosis drug Fosamax was dismissed Nov. 23, has appealed the district court's finding that her expert witnesses failed to show a connection between the drug and a degenerative jawbone disease....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.